Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vestipitant/paroxetine crossover study in tinnitus with hearing loss
2006-003295-36Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in tinnitus comparing Vestipitant + paroxetine sequence, Vestipitant alone sequence and Placebo sequence (3 arms). Primary endpoint: Change in tinnitus loudness on visual analog scale. Started Sep 2006; status: completed.
02
Drugs
vestipitantparoxetine
03
Conditions
tinnitus
Beyond the preview
Go deeper on 2006-003295-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003295-36.